Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Overview of Algae01:28

Overview of Algae

1.2K
The kingdom Archaeplastida encompasses red and green algae, along with land plants. Unlike other protists with chloroplasts that arose through secondary endosymbiosis, only red and green algae originated from primary endosymbiotic events. This diverse group of eukaryotic organisms contains chlorophyll and performs oxygenic photosynthesis.Algae exist in various forms, from large brown kelp in coastal waters to green scum in puddles and stains on rocks or soil. Some species are responsible for...
1.2K
Preclinical Development: Overview01:28

Preclinical Development: Overview

6.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.1K
Green Algae01:21

Green Algae

968
Green algae, also referred to as chlorophytes, are different from red algae in having the chloroplasts containing chlorophylls a and b, which give them their distinct green hue. However, they lack phycobiliproteins, preventing them from developing the red or blue-green pigmentation seen in red algae. In terms of photosynthetic pigment composition, green algae closely resemble plants and share a close evolutionary relationship with them. Taxonomically Green algae belong to Phylum Chlorophyta in...
968
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

274
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
274
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

380
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
380
Red Algae01:23

Red Algae

1.3K
Red algae, also known as rhodophytes, are primarily found in marine environments, though some species inhabit freshwater and terrestrial ecosystems. These organisms exist in both unicellular and multicellular forms, with some multicellular varieties reaching macroscopic sizes.As phototrophic organisms, red algae contain chlorophyll a; however, their chloroplasts lack chlorophyll b. Instead, they possess phycobiliproteins, which serve as major light-harvesting pigments, similar to those found in...
1.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Can microalgal omega-3 PUFA production systems remain viable as GM plant sources emerge?

Bioresource technology·2025
Same author

Co-Cultivation With New Glucose-Sparing Chlorella Algae Boosts Tissue Culture Efficiency by Reducing Cell Waste.

Biotechnology journal·2025
Same author

A cyclical marker system enables indefinite series of oligonucleotide-directed gene editing in Chlamydomonas reinhardtii.

Plant physiology·2024
Same author

Waste to protein: A systematic review of a century of advancement in microbial fermentation of agro-industrial byproducts.

Comprehensive reviews in food science and food safety·2024
Same author

Anticipatory regulation for pandemic responses: are we there yet?

Trends in biotechnology·2024
Same author

Environmental and nuclear influences on microalgal chloroplast gene expression.

Trends in plant science·2023
Same journal

Correction: Assalve et al. Marine Algal Metabolites as Cellular Antioxidants: A Study of Caulerpin and Caulerpinic Acid in <i>Saccharomyces cerevisiae</i>. <i>Mar. Drugs</i> 2025, <i>23</i>, 338.

Marine drugs·2026
Same journal

Laurinterol, the Main <i>Smart Secondary Metabolite</i> Among Lauranes and Cyclolauranes.

Marine drugs·2026
Same journal

Red Light Enhances Biomass and Bioactive Compounds Through Photosynthetic Acclimation in <i>Anabaena variabilis</i>.

Marine drugs·2026
Same journal

Seaweed-Derived Extract Targets Porphyr'ageing to Modulate the Visible Signs of Aging in Human Skin.

Marine drugs·2026
Same journal

The Potential and Prospects of Marine Drugs in Intervening Nerve-Tumor Crosstalk.

Marine drugs·2026
Same journal

Amylimycins A-C, New Bacillomycin D Analogs from Marine-Derived <i>Bacillus amyloliquefaciens</i>.

Marine drugs·2026
查看所有相关文章

相关实验视频

Updated: Feb 27, 2026

Coupling Carbon Capture from a Power Plant with Semi-automated Open Raceway Ponds for Microalgae Cultivation
08:17

Coupling Carbon Capture from a Power Plant with Semi-automated Open Raceway Ponds for Microalgae Cultivation

Published on: August 14, 2020

6.0K

导航基于微藻产品开发的分析框架 - 调整商业化和监管途径

Galey Tenzin1, Kira Schipper2, Harshit Rathore1

  • 1Queensland Alliance for Agriculture and Food Innovation, The University of Queensland, Brisbane 4072, Australia.

Marine drugs
|February 26, 2026
PubMed
概括
此摘要是机器生成的。

微藻行业正在重新出现,为食品,能源和气候提供解决方案. 本研究引入了一个框架,用于导航微藻产品的创新途径,市场进入和商业竞争力.

关键词:
竞争优势 竞争优势市场经济学的市场经济学.微藻的创新是微藻的创新多重标准的决策.通过监管途径进行导航.新产品开发新产品的开发.快速进入市场的速度.

更多相关视频

Analysis of Fatty Acid Content and Composition in Microalgae
07:44

Analysis of Fatty Acid Content and Composition in Microalgae

Published on: October 1, 2013

61.6K
Cultivation of Green Microalgae in Bubble Column Photobioreactors and an Assay for Neutral Lipids
11:08

Cultivation of Green Microalgae in Bubble Column Photobioreactors and an Assay for Neutral Lipids

Published on: January 7, 2019

22.6K

相关实验视频

Last Updated: Feb 27, 2026

Coupling Carbon Capture from a Power Plant with Semi-automated Open Raceway Ponds for Microalgae Cultivation
08:17

Coupling Carbon Capture from a Power Plant with Semi-automated Open Raceway Ponds for Microalgae Cultivation

Published on: August 14, 2020

6.0K
Analysis of Fatty Acid Content and Composition in Microalgae
07:44

Analysis of Fatty Acid Content and Composition in Microalgae

Published on: October 1, 2013

61.6K
Cultivation of Green Microalgae in Bubble Column Photobioreactors and an Assay for Neutral Lipids
11:08

Cultivation of Green Microalgae in Bubble Column Photobioreactors and an Assay for Neutral Lipids

Published on: January 7, 2019

22.6K

科学领域:

  • 生物技术与可持续资源
  • 工业微生物学 工业微生物学
  • 市场分析市场分析

背景情况:

  • 全球微藻产业正在经历复苏,其动力来自于其应对食品,能源,营养药品,化品,药品和气候变化缓解等关键挑战的潜力.
  • 尽管技术进步,但从微藻创新到市场竞争力的道路是复杂的,需要整合技术准备,监管合规,财务需求和市场动态.

研究的目的:

  • 提出一个新的分析框架,以数据为基础,基于证据的方法来导航微藻的创新途径到市场.
  • 整合增值机会,并确定市场前竞争阶段和竞争阶段的关键阶段,符合监管要求.

主要方法:

  • 开发一个综合技术准备水平 (TRL),研发支出,专利趋势,产品推出,市场规模和竞争格局分析的分析框架.
  • 纳入监管要求和企业/行业层面分析,用于市场前和市场上阶段.
  • 利用跨学科的经验,为食品和饮料行业和微藻工艺开发交互式仪表板.

主要成果:

  • 该框架整合了多种分析,以确定市场机会并评估企业的竞争力.
  • 它提供了一种结构化的方法,以了解微藻产品的竞争前 (市场推出前) 和竞争 (市场上) 景观.
  • 该研究承认存在局限性,包括新兴产品的数据可用性和依赖二次来源的市场估计.

结论:

  • 提出的框架指导企业和研究人员通过新兴的微藻行业复杂的产品开发格局.
  • 它为导航监管和商业路径提供了信息化的决策.
  • 综合方法提高了微藻行业成功进入市场和持续竞争的潜力.